// BIOCHEMISTRY Questions
// Auto-generated from questions.ts
// Total Questions: 29

import { Question } from '../types';

export const questions: Question[] = [
{
    id: "neet-pg-2024-22",
    subjectId: "biochemistry",
    chapterId: "neet-pg-2024",
    question: "Clinical scenario about homocystinuria, which vitamin to be supplemented?",
    options: [
      "Thiamine",
      "Vitamin B6",
      "Biotin",
      "Pyruvate"
    ],
    correctAnswer: 1,
    explanation: "‚úÖ ANSWER: **Vitamin B6 (Pyridoxine) (Option B)**\n\nüî¨ DETAILED EXPLANATION:\n\n**Homocystinuria** is an **inborn error of metabolism** characterized by **elevated homocysteine** in blood and urine due to enzyme deficiencies in homocysteine metabolism.\n\n‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨\n\nüìå NORMAL METHIONINE METABOLISM:\n\n**PATHWAY:**\n\n**Methionine** (essential amino acid)\n\n   ‚Üì (SAM formation)\n\n**S-Adenosyl methionine (SAM)**\n\n   ‚Üì (methylation reactions)\n\n**S-Adenosyl homocysteine**\n\n   ‚Üì\n\n**HOMOCYSTEINE** üéØ (CRITICAL JUNCTION)\n\n   ‚Üì ‚Üì\n\n**Two pathways:**\n\n**PATHWAY 1: TRANSSULFURATION** ‚≠ê‚≠ê‚≠ê\n\n**Homocysteine** ‚Üí (CBS + **Vitamin B6**) ‚Üí **Cystathionine** ‚Üí (CGL + B6) ‚Üí **Cysteine**\n\n**PATHWAY 2: REMETHYLATION**\n\n**Homocysteine** ‚Üí (MS + Vitamin B12 + Folate) ‚Üí **Methionine**\n\n‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨\n\nüéØ HOMOCYSTINURIA TYPES:\n\n**TYPE 1 (CLASSIC)** ‚≠ê‚≠ê‚≠ê **Most Common (90%)**\n\n**DEFECT:**\n‚Ä¢ **Cystathionine Œ≤-synthase (CBS) deficiency** ‚≠ê\n‚Ä¢ **Autosomal recessive**\n‚Ä¢ Gene on chromosome **21q22**\n\n**RESULT:**\n‚Ä¢ ‚Üë‚Üë‚Üë **Homocysteine** in blood/urine\n‚Ä¢ ‚Üë **Methionine** (accumulates)\n‚Ä¢ ‚Üì **Cysteine** (becomes essential)\n\n**TREATMENT:** **VITAMIN B6 (Pyridoxine)** ‚≠ê‚≠ê‚≠ê **(ANSWER)**\n\n‚Ä¢ **Cofactor** for CBS enzyme\n‚Ä¢ **50% of patients B6-responsive**\n‚Ä¢ High-dose: **100-1000 mg/day**\n‚Ä¢ If responsive: ‚Üì‚Üì homocysteine levels\n‚Ä¢ **Betaine** + low methionine diet (if non-responsive)\n\n**TYPE 2:**\n‚Ä¢ **Methionine synthase deficiency**\n‚Ä¢ **Vitamin B12** (cobalamin) therapy\n\n**TYPE 3:**\n‚Ä¢ **MTHFR deficiency**\n‚Ä¢ **Folate** therapy\n\n‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨\n\nüî¨ CLINICAL FEATURES (Classic CBS Deficiency):\n\n**\"4 M's\" MNEMONIC:**\n\n**1. MARFANOID habitus** ‚≠ê‚≠ê‚≠ê\n‚Ä¢ **Tall, thin** build\n‚Ä¢ **Long limbs** (dolichostenomelia)\n‚Ä¢ **Arachnodactyly** (spider fingers)\n‚Ä¢ **Pectus excavatum/carinatum**\n‚Ä¢ **Scoliosis**\n\n**2. MENTAL retardation** ‚≠ê\n‚Ä¢ **IQ <50** in untreated\n‚Ä¢ **Seizures** (20-30%)\n‚Ä¢ **Psychiatric symptoms**\n‚Ä¢ **Developmental delay**\n\n**3. MYOPIA / OCULAR** ‚≠ê‚≠ê‚≠ê\n‚Ä¢ **Ectopia lentis** (lens dislocation) **PATHOGNOMONIC**\n  ‚Üí **Downward & inward** displacement ‚≠ê\n  ‚Üí vs Marfan: upward & outward\n‚Ä¢ **Severe myopia**\n‚Ä¢ **Retinal detachment**\n‚Ä¢ **Glaucoma**\n‚Ä¢ **Optic atrophy**\n\n**4. THROMBOEMBOLISM** ‚≠ê‚≠ê‚≠ê\n‚Ä¢ **Most dangerous complication** ‚ö†Ô∏è\n‚Ä¢ **Arterial & venous thrombosis**\n‚Ä¢ **Stroke** (even in children)\n‚Ä¢ **MI (myocardial infarction)**\n‚Ä¢ **Pulmonary embolism**\n‚Ä¢ Can occur during **anesthesia**\n\n**OTHER FEATURES:**\n‚Ä¢ **Fair hair & skin** (hypopigmentation)\n‚Ä¢ **Malar flush**\n‚Ä¢ **Osteoporosis**\n‚Ä¢ **Genu valgum**\n\n‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨\n\n‚ùå WHY OTHER OPTIONS ARE INCORRECT:\n\n**A. Thiamine (Vitamin B1)** ‚ùå\n‚Ä¢ Cofactor for: **Pyruvate dehydrogenase**, Œ±-ketoglutarate DH\n‚Ä¢ Deficiency: **Beriberi**, Wernicke-Korsakoff\n‚Ä¢ NOT involved in homocysteine metabolism\n\n**C. Biotin (Vitamin B7)** ‚ùå\n‚Ä¢ Cofactor for: **Carboxylases** (Acetyl-CoA carboxylase, Pyruvate carboxylase)\n‚Ä¢ Deficiency: **Dermatitis**, alopecia\n‚Ä¢ NOT involved in homocysteine metabolism\n\n**D. Pyruvate** ‚ùå\n‚Ä¢ NOT a vitamin\n‚Ä¢ End product of **glycolysis**\n‚Ä¢ No role in homocysteine metabolism\n\n‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨\n\nüî¨ DIAGNOSIS:\n\n**SCREENING:**\n‚Ä¢ **Newborn screening** (some countries)\n‚Ä¢ **Elevated homocysteine** in blood/urine ‚≠ê\n‚Ä¢ **Positive sodium nitroprusside test** (cyanide-nitroprusside)\n\n**CONFIRMATORY:**\n‚Ä¢ **Plasma total homocysteine** >100 Œºmol/L (N: <15)\n‚Ä¢ **Plasma methionine** elevated (>200 Œºmol/L)\n‚Ä¢ **Plasma cysteine** low\n‚Ä¢ **CBS enzyme activity** in fibroblasts\n‚Ä¢ **Genetic testing**\n\n‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨\n\nüíä COMPREHENSIVE MANAGEMENT:\n\n**1. VITAMIN B6 (Pyridoxine)** ‚≠ê‚≠ê‚≠ê **FIRST-LINE**\n‚Ä¢ **100-1000 mg/day**\n‚Ä¢ Trial for **3-6 weeks**\n‚Ä¢ Check response (‚Üì homocysteine)\n‚Ä¢ **50% patients responsive**\n\n**2. BETAINE (Trimethylglycine)**\n‚Ä¢ If **B6 non-responsive**\n‚Ä¢ **6-9 g/day** (divided doses)\n‚Ä¢ Remethylates homocysteine ‚Üí methionine\n\n**3. DIETARY MODIFICATION**\n‚Ä¢ **Low methionine diet**\n‚Ä¢ ‚Üì Protein (especially animal)\n‚Ä¢ **Cysteine supplementation** (becomes essential)\n\n**4. FOLATE & VITAMIN B12**\n‚Ä¢ Support remethylation pathway\n\n**5. ANTICOAGULATION** (if thrombosis)\n‚Ä¢ Low-dose **aspirin** prophylaxis\n\n‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨‚ñ¨\n\nüí° KEY POINT FOR EXAM:\n\n**Homocystinuria (CBS deficiency) = Vitamin B6 treatment** ‚≠ê‚≠ê‚≠ê\n\n**Remember:** \"**B6** for **CBS** deficiency!\"\n\n**Classic triad:**\n‚Ä¢ **Ectopia lentis** (downward & inward) ‚≠ê\n‚Ä¢ **Marfanoid habitus**\n‚Ä¢ **Thromboembolic events** (stroke, MI)\n\n**Treatment:**\n‚Ä¢ **Pyridoxine (B6)** = FIRST-LINE (cofactor for CBS)\n‚Ä¢ **Betaine** if B6 non-responsive\n‚Ä¢ Low methionine diet + cysteine supplementation",
    difficulty: "medium",
    imageUrl: "/images/questions/page8_img19.jpg",
    year: 2024
  },{
    id: "neet-pg-2024-shift2-15",
    subjectId: "biochemistry",
    chapterId: "neet-pg-2024",
    question: "A 5-year-old girl was washing her doll with shampoo containing a chemical Rotenone. Her mother noticed her in unconscious state. Which of the following Complex is inhibited by the above-mentioned chemical?",
    options: [
      "NADH Dehydrogenase (Complex I)",
      "Succinate DH (Complex II)",
      "Cytochrome C (Complex III)",
      "Cytochrome oxidase (Complex IV)"
    ],
    correctAnswer: 0,
    explanation: "**Rotenone** is a classic **Complex I (NADH dehydrogenase) inhibitor** in the **electron transport chain**. Mechanism: blocks **electron transfer** from NADH to ubiquinone, halting **ATP production**. Clinical effects: **CNS toxicity** (mitochondria-rich), **Parkinson-like symptoms** (damages substantia nigra). Also used as **pesticide** and linked to **Parkinson's disease** development. Other Complex I inhibitors: **barbiturates**, **piericidin A**.",
    difficulty: "medium",
    year: 2024
  },{
    id: "neet-pg-2024-shift2-16",
    subjectId: "biochemistry",
    chapterId: "neet-pg-2024",
    question: "A patient present with dilated cardiomyopathy on x-ray and hypoglycemia, floppy baby, hypotonia, hepatomegaly. What is most likely diagnosis?",
    options: [
      "Pompe's disease",
      "Von Gierke's disease",
      "Ebstein anomaly"
    ],
    correctAnswer: 0,
    explanation: "**Pompe's disease** (Glycogen Storage Disease Type II) is caused by **acid maltase (Œ±-1,4-glucosidase) deficiency**. Key features: **Cardiomegaly/cardiomyopathy** (massive), **hepatomegaly**, **hypotonia** (floppy baby), **macroglossia**, normal blood glucose (glycogen in lysosomes, not cytoplasm). ECG: **short PR**, **large QRS**. Infantile form is **fatal by 2 years**. Diagnosis: **enzyme assay**, **muscle biopsy** (vacuoles with glycogen).",
    difficulty: "medium",
    year: 2024
  },{
    id: "neet-pg-2024-shift2-17",
    subjectId: "biochemistry",
    chapterId: "neet-pg-2024",
    question: "A 15-year-old child with difficulty in exercise, affected oxidation of long chain fatty acids and biopsy muscle shows fat vacuoles. Which of the following is the diagnosis?",
    options: [
      "Carnitine deficiency",
      "FA synthase defect",
      "LPL defect",
      "LDL defect"
    ],
    correctAnswer: 0,
    explanation: "**Carnitine deficiency** impairs **long-chain fatty acid oxidation** as carnitine is required for **fatty acid transport** into mitochondria (**CPT-I system**). Clinical features: **exercise intolerance**, **muscle weakness**, **hypoglycemia** (impaired gluconeogenesis), **cardiomyopathy**, **hepatomegaly**. Muscle biopsy: **lipid vacuoles** (fat accumulation). Types: **Primary** (genetic) or **Secondary** (dialysis, valproate). Treatment: **L-carnitine supplementation**.",
    difficulty: "medium",
    year: 2024
  },{
    id: "neet-pg-2024-shift2-18",
    subjectId: "biochemistry",
    chapterId: "neet-pg-2024",
    question: "A Farmer was on maize as stapled diet develops rash on face, neck and hand. Which of the following vitamin should be given in the treatment?",
    options: [
      "Niacin (Vitamin B3)",
      "Thiamine (Vitamin B1)"
    ],
    correctAnswer: 0,
    explanation: "**Pellagra** (Niacin/Vitamin B3 deficiency) presents with **4 D's**: **Dermatitis** (photosensitive rash on sun-exposed areas - face, neck, hands), **Diarrhea**, **Dementia**, **Death**. Characteristic: **Casal's necklace** (hyperpigmented rash around neck). Cause: **maize-based diet** (low niacin, high leucine which inhibits niacin). Maize lacks **tryptophan** (niacin precursor). Treatment: **Niacin supplementation** + balanced diet.",
    difficulty: "easy",
    year: 2024
  },{
    id: "neet-pg-2024-shift2-19",
    subjectId: "biochemistry",
    chapterId: "neet-pg-2024",
    question: "A patient develops mouth ulcers on treatment with Methotrexate. Which of the following will decrease with this drug?",
    options: [
      "UMP",
      "TMP (Thymidine monophosphate)",
      "CMP"
    ],
    correctAnswer: 1,
    explanation: "**Methotrexate** inhibits **dihydrofolate reductase (DHFR)**, preventing **tetrahydrofolate (THF) formation**. THF is essential for **thymidine synthesis** (dTMP from dUMP via thymidylate synthase). Result: **decreased TMP** ‚Üí impaired **DNA synthesis** ‚Üí affects **rapidly dividing cells** (bone marrow, GI mucosa). Side effects: **mucositis** (mouth ulcers), **myelosuppression**. **Leucovorin (folinic acid) rescue** bypasses DHFR block.",
    difficulty: "medium",
    year: 2024
  },{
    id: "neet-pg-2024-shift2-20",
    subjectId: "biochemistry",
    chapterId: "neet-pg-2024",
    question: "Increased Km and unchanged Vmax is seen in which of the following inhibition?",
    options: [
      "Competitive inhibition",
      "Noncompetitive inhibition",
      "Uncompetitive inhibition"
    ],
    correctAnswer: 0,
    explanation: "**Competitive inhibition**: Inhibitor competes with substrate for **active site**. Effect: **Increased Km** (decreased affinity, more substrate needed), **Unchanged Vmax** (can be overcome by high substrate concentration). Example: **Malonate inhibits succinate dehydrogenase**. **Noncompetitive**: Decreased Vmax, unchanged Km. **Uncompetitive**: Both Km and Vmax decrease. **Lineweaver-Burk plot**: Competitive shows lines intersecting on Y-axis.",
    difficulty: "medium",
    year: 2024
  },{
    id: "neet-pg-2024-shift2-21",
    subjectId: "biochemistry",
    chapterId: "neet-pg-2024",
    question: "A drug is given for the treatment of hyperlipidemia. Facial flushing was noted. Which of the following drug causes this side effect?",
    options: [
      "Nicotinic acid (Niacin)"
    ],
    correctAnswer: 0,
    explanation: "**Nicotinic acid (Niacin)** in **high doses** is used for **hyperlipidemia**. Mechanism: **decreases VLDL synthesis**, **increases HDL**. Major side effect: **Cutaneous flushing** (face, upper body) due to **prostaglandin-mediated vasodilation**. Prevention: **Aspirin 30 min before** niacin, **gradual dose titration**, **take with meals**. Other effects: **hyperglycemia**, **hyperuricemia**, **hepatotoxicity**. **Extended-release** formulations reduce flushing.",
    difficulty: "easy",
    year: 2024
  },{
    id: "neet-pg-2024-shift2-22",
    subjectId: "biochemistry",
    chapterId: "neet-pg-2024",
    question: "Increased chylomicron, lipemic serum is seen in:",
    options: [
      "Lipoprotein lipase deficiency"
    ],
    correctAnswer: 0,
    explanation: "**Lipoprotein lipase (LPL) deficiency** (Type I Hyperlipoproteinemia) causes **massive chylomicronemia**. LPL breaks down **chylomicrons and VLDL** in capillaries. Deficiency ‚Üí **chylomicrons accumulate** ‚Üí **lipemic (milky) serum**. Clinical features: **eruptive xanthomas**, **lipemia retinalis**, **hepatosplenomegaly**, **recurrent pancreatitis**. Diagnosis: **triglycerides >1000 mg/dL**, **creamy layer** on standing serum. Treatment: **very low-fat diet** (<10g/day).",
    difficulty: "medium",
    year: 2024
  },{
    id: "neet-pg-2024-shift2-23",
    subjectId: "biochemistry",
    chapterId: "neet-pg-2024",
    question: "Which micronutrient deficiency causes anemia, gum bleeding and x-ray changes - White Frankel line?",
    options: [
      "Copper",
      "Iron",
      "Vitamin C (Scurvy)",
      "Zinc"
    ],
    correctAnswer: 2,
    explanation: "**Scurvy** (Vitamin C deficiency) presents with: **Anemia** (impaired iron absorption, folate metabolism), **gum bleeding** (scorbutic gingivitis), **perifollicular hemorrhages**, **White Frankel line** (dense metaphyseal line on X-ray due to impaired osteoid formation), **subperiosteal hemorrhage**. Vitamin C is essential for **collagen synthesis** (hydroxylation of proline/lysine). Treatment: **Vitamin C supplementation**.",
    difficulty: "medium",
    year: 2024
  },{
    id: "neet-pg-2024-shift2-24",
    subjectId: "biochemistry",
    chapterId: "neet-pg-2024",
    question: "Which of the following enzyme is deficient in patient with Phenylketonuria if phenylalanine hydroxylase level is normal?",
    options: [
      "Dihydrobiopterin reductase"
    ],
    correctAnswer: 0,
    explanation: "**Atypical PKU** (2-3% cases) is caused by **dihydrobiopterin reductase deficiency** or **BH4 synthesis defects**. **BH4 (tetrahydrobiopterin)** is a **cofactor** for phenylalanine hydroxylase. Without BH4, even normal phenylalanine hydroxylase **cannot function**. Additional effects: **tyrosine and tryptophan hydroxylases** also need BH4 ‚Üí **neurotransmitter deficiency** (dopamine, serotonin, norepinephrine) ‚Üí **severe neurological damage**. Treatment: **BH4 supplementation** + **neurotransmitter precursors** (L-DOPA, 5-HTP).",
    difficulty: "hard",
    year: 2024
  },{
    id: "neet-pg-2024-shift2-25",
    subjectId: "biochemistry",
    chapterId: "neet-pg-2024",
    question: "A tall stature, long digits, long arm span and subluxation of lens is seen in which of the following defect?",
    options: [
      "Fibrillin-1",
      "Collagen"
    ],
    correctAnswer: 0,
    explanation: "**Marfan syndrome** is caused by **Fibrillin-1 gene mutation** (FBN1 on chromosome 15). Fibrillin is a **glycoprotein** in **elastic fibers**. Clinical features: **Skeletal**: tall stature, long limbs, arachnodactyly, pectus deformity, **scoliosis**. **Ocular**: **ectopia lentis** (upward lens subluxation). **Cardiovascular**: **aortic root dilatation**, **mitral valve prolapse**, **aortic dissection** (major cause of death). Diagnosis: **Ghent criteria**. Treatment: **Œ≤-blockers**, **ARBs**, surgical repair of aneurysms.",
    difficulty: "easy",
    year: 2024
  },{
    id: "neet-pg-2024-shift2-26",
    subjectId: "biochemistry",
    chapterId: "neet-pg-2024",
    question: "A male patient with pallor, weakness and easy fatigability. His blood report shows MCV 53, TIBC - Increased. What is your diagnosis?",
    options: [
      "Iron deficiency anemia"
    ],
    correctAnswer: 0,
    explanation: "**Iron deficiency anemia** is confirmed by: **Microcytic** (MCV <80, here 53), **hypochromic** anemia. Lab: **Low serum iron**, **High TIBC** (total iron binding capacity - increased transferrin), **Low ferritin** (best marker for stores), **Low transferrin saturation** (<15%). Causes: **chronic blood loss** (GI, menstrual), **malabsorption**, **poor intake**. Clinical: **pallor**, **fatigue**, **koilonychia**, **glossitis**. Treatment: **Oral iron** (ferrous sulfate) + **treat underlying cause**.",
    difficulty: "easy",
    year: 2024
  },{
    id: "neet-pg-2024-shift2-27",
    subjectId: "biochemistry",
    chapterId: "neet-pg-2024",
    question: "Which of the following is methanol poisoning derivative?",
    options: [
      "Formic acid + Lactic acid",
      "Acetic acid"
    ],
    correctAnswer: 0,
    explanation: "**Methanol poisoning**: Methanol ‚Üí **Formaldehyde** (via alcohol dehydrogenase) ‚Üí **Formic acid** (via aldehyde dehydrogenase). **Formic acid** causes: **metabolic acidosis** (with high anion gap), **optic nerve damage** ‚Üí **blindness**, **basal ganglia necrosis**. **Lactic acidosis** also develops due to impaired cellular respiration. Treatment: **Fomepizole** (alcohol dehydrogenase inhibitor) or **ethanol** (competitive inhibitor), **bicarbonate** (correct acidosis), **hemodialysis**, **folate** (enhances formic acid metabolism).",
    difficulty: "medium",
    year: 2024
  },{
    id: "neet-pg-2023-20",
    subjectId: "biochemistry",
    chapterId: "neet-pg-2023",
    question: "Which of the following clotting factors is needed for gamma-glutamyl carboxylase?",
    options: [
      "Factors II, VIII, IX, X",
      "Factors II, VII, IX, and X",
      "Factors II, VII, IX, XI",
      "Factors II, VIII, X, XI r",
    ],
    correctAnswer: 1,
    explanation: "‚úÖ ANSWER: **Factors II, VII, IX, and X (Option B)**\n\nüî¨ **VITAMIN K-DEPENDENT CLOTTING FACTORS:**\n\n**GAMMA-GLUTAMYL CARBOXYLASE:**\n‚Ä¢ **Enzyme** that requires **Vitamin K** as cofactor ‚≠ê‚≠ê‚≠ê\n‚Ä¢ **Function:** **Post-translational modification** of clotting factors\n‚Ä¢ **Carboxylates glutamic acid residues** ‚Üí Œ≥-carboxyglutamic acid (Gla)\n\n**VITAMIN K-DEPENDENT FACTORS** ‚≠ê‚≠ê‚≠ê:\n\n**\"1972\" Mnemonic** ‚≠ê:\n‚Ä¢ **Factor II** (Prothrombin) ‚≠ê\n‚Ä¢ **Factor VII** (Proconvertin) ‚≠ê\n‚Ä¢ **Factor IX** (Christmas factor) ‚≠ê\n‚Ä¢ **Factor X** (Stuart-Prower factor) ‚≠ê\n\n**+ Regulatory proteins:**\n‚Ä¢ **Protein C** ‚≠ê\n‚Ä¢ **Protein S** ‚≠ê\n\n**MECHANISM:**\n\n**Vitamin K cycle:**\n1. **Vitamin K (reduced form)** is cofactor for Œ≥-glutamyl carboxylase\n2. **Carboxylation** of glutamic acid residues on factors II, VII, IX, X\n3. **Œ≥-carboxyglutamic acid (Gla)** residues created\n4. **Gla residues bind Ca¬≤‚Å∫** ‚Üí Factors bind to **phospholipid membranes**\n5. **Essential** for clotting cascade activation\n\n**Without carboxylation:**\n‚Ä¢ **PIVKA** (Proteins Induced by Vitamin K Absence) ‚≠ê\n‚Ä¢ **Non-functional** clotting factors\n‚Ä¢ **Cannot bind Ca¬≤‚Å∫** or phospholipid surfaces\n\n**CLINICAL SIGNIFICANCE:**\n\n**Vitamin K deficiency:**\n‚Ä¢ **Hemorrhagic disease of newborn** ‚≠ê\n‚Ä¢ **Malabsorption** (biliary obstruction, celiac disease)\n‚Ä¢ **Prolonged PT/aPTT**\n‚Ä¢ **Treatment:** Vitamin K supplementation\n\n**Warfarin:**\n‚Ä¢ **Vitamin K antagonist** ‚≠ê‚≠ê‚≠ê\n‚Ä¢ **Inhibits** vitamin K epoxide reductase (VKORC1)\n‚Ä¢ ‚Üí **Blocks vitamin K recycling**\n‚Ä¢ ‚Üí **Impaired carboxylation** of factors II, VII, IX, X\n‚Ä¢ ‚Üí **Anticoagulation**\n‚Ä¢ **Monitored by PT/INR**\n\n**Factor VII has shortest half-life** (6 hours):\n‚Ä¢ **PT** prolonged **first** with warfarin ‚≠ê\n‚Ä¢ **aPTT** prolonged later (factors II, IX, X)\n\n**COAGULATION PATHWAYS:**\n\n**Extrinsic pathway:**\n‚Ä¢ **Factor VII** ‚≠ê (Vitamin K-dependent)\n\n**Intrinsic pathway:**\n‚Ä¢ **Factor IX** ‚≠ê (Vitamin K-dependent)\n\n**Common pathway:**\n‚Ä¢ **Factor X** ‚≠ê (Vitamin K-dependent)\n‚Ä¢ **Factor II (Prothrombin)** ‚≠ê (Vitamin K-dependent)\n\n**WHY OTHER OPTIONS ARE WRONG:**\n\n**Factor VIII** ‚ùå:\n‚Ä¢ **NOT Vitamin K-dependent**\n‚Ä¢ Synthesized in **liver and endothelial cells**\n‚Ä¢ Deficiency ‚Üí **Hemophilia A**\n‚Ä¢ **NOT carboxylated** by Œ≥-glutamyl carboxylase\n\n**Factor XI** ‚ùå:\n‚Ä¢ **NOT Vitamin K-dependent**\n‚Ä¢ Deficiency ‚Üí **Hemophilia C**\n‚Ä¢ **NOT carboxylated**\n\n**SUMMARY TABLE:**\n\n| Factor | Vitamin K | Half-life | Pathway |\n|--------|-----------|-----------|----------|\n| **II** | ‚úÖ Yes | 60h | Common |\n| **VII** | ‚úÖ Yes | **6h** ‚≠ê | Extrinsic |\n| **VIII** | ‚ùå No | 12h | Intrinsic |\n| **IX** | ‚úÖ Yes | 24h | Intrinsic |\n| **X** | ‚úÖ Yes | 40h | Common |\n| **XI** | ‚ùå No | 52h | Intrinsic |\n\nüí° **KEY:** **Vitamin K-dependent = II, VII, IX, X (+ Protein C, S) - \"1972\"** ‚≠ê‚≠ê‚≠ê",
    difficulty: "medium",
    year: 2023
  },{
    id: "neet-pg-2023-21",
    subjectId: "biochemistry",
    chapterId: "neet-pg-2023",
    question: "d A patient presented with diarrhea, dermatitis, and dementia. Which of the following vitamin deficiencies would you suspect in this patient?",
    options: [
      "Vitamin B3 deficiency",
      "Vitamin B1 deficiency L",
      "Vitamin B6 deficiency p",
      "Vitamin B12 deficiency",
    ],
    correctAnswer: 0,
    explanation: "‚úÖ ANSWER: **Vitamin B3 (Niacin) deficiency (Option A)**\n\nüî¨ **PELLAGRA (Niacin Deficiency):**\n\n**CLASSIC TRIAD - \"3 D's\"** ‚≠ê‚≠ê‚≠ê:\n1. **Diarrhea** ‚≠ê\n2. **Dermatitis** ‚≠ê\n3. **Dementia** ‚≠ê\n\n**(+ 4th D: Death if untreated)**\n\n**VITAMIN B3 (NIACIN):**\n‚Ä¢ **Nicotinic acid** + **Nicotinamide**\n‚Ä¢ **Precursor:** Tryptophan (60mg tryptophan ‚Üí 1mg niacin)\n‚Ä¢ **Function:** Component of **NAD/NADP** (energy metabolism)\n\n**CAUSES:**\n‚Ä¢ **Dietary deficiency** (corn-based diets) ‚≠ê\n  - Corn has niacin in bound form (unavailable)\n  - Low tryptophan content\n‚Ä¢ **Carcinoid syndrome** (tryptophan ‚Üí serotonin instead of niacin)\n‚Ä¢ **Hartnup disease** (tryptophan malabsorption)\n‚Ä¢ **Isoniazid therapy** (interferes with niacin synthesis)\n‚Ä¢ **Alcoholism**\n\n**CLINICAL MANIFESTATIONS:**\n\n**1. DERMATITIS** ‚≠ê‚≠ê‚≠ê:\n‚Ä¢ **\"Casal's necklace\"** - hyperpigmented rash around neck ‚≠ê\n‚Ä¢ **Photosensitive** (sun-exposed areas)\n‚Ä¢ **Symmetric distribution**\n‚Ä¢ **Resembles sunburn** ‚Üí becomes rough, scaly\n‚Ä¢ **Glove-and-stocking** distribution on extremities\n\n**2. DIARRHEA:**\n‚Ä¢ **Watery, bloody**\n‚Ä¢ **Glossitis** (beefy red tongue) ‚≠ê\n‚Ä¢ **Cheilitis** (cracked lips)\n‚Ä¢ **GI mucosal atrophy**\n\n**3. DEMENTIA:**\n‚Ä¢ **Confusion, memory loss**\n‚Ä¢ **Depression, anxiety**\n‚Ä¢ **Psychosis** (severe cases)\n‚Ä¢ **Encephalopathy**\n\n**DIAGNOSIS:**\n‚Ä¢ **Low urinary N-methylnicotinamide**\n‚Ä¢ **Clinical diagnosis** (classic triad)\n\n**TREATMENT:**\n‚Ä¢ **Nicotinamide 100-500 mg/day** ‚≠ê‚≠ê‚≠ê\n‚Ä¢ Or **Nicotinic acid**\n‚Ä¢ **Response within days** (dermatitis improves first)\n\n**DIFFERENTIAL:**\n\n**Vitamin B1 (Thiamine) deficiency** ‚ùå:\n‚Ä¢ **Beriberi:** Heart failure (wet) or neuropathy (dry)\n‚Ä¢ **Wernicke-Korsakoff:** Confusion, ataxia, ophthalmoplegia\n‚Ä¢ **NO dermatitis**\n\n**Vitamin B6 (Pyridoxine) deficiency** ‚ùå:\n‚Ä¢ **Peripheral neuropathy**\n‚Ä¢ **Sideroblastic anemia**\n‚Ä¢ **Seizures** (infants)\n‚Ä¢ **NO dermatitis or diarrhea**\n\n**Vitamin B12 (Cobalamin) deficiency** ‚ùå:\n‚Ä¢ **Megaloblastic anemia**\n‚Ä¢ **Subacute combined degeneration** (spinal cord)\n‚Ä¢ **Glossitis**\n‚Ä¢ **NO photosensitive dermatitis**\n\nüí° **KEY:** **3 D's (Diarrhea + Dermatitis + Dementia) = Pellagra (Niacin/B3 deficiency)** ‚≠ê‚≠ê‚≠ê",
    difficulty: "medium",
    imageUrl: "/images/questions/2023/page10_img6.jpeg",
    year: 2023
  },{
    id: "neet-pg-2023-22",
    subjectId: "biochemistry",
    chapterId: "neet-pg-2023",
    question: "A young boy presents to the OPD with hypoglycemia and muscle cramps, on exertion or while playing. Then he becomes normal after resting for a while. These episodes are recurrent after a period of activity. He has decreased serum lactate and glucose levels. Which of the following diseases is he most likely to be suffering from?",
    options: [
      "McArdle disease",
      "Hers disease",
      "Cori's disease",
      "Andersen disease",
    ],
    correctAnswer: 0,
    explanation: "‚úÖ ANSWER: **McArdle disease (Option A)**\n\nüî¨ **McARDLE DISEASE (Glycogen Storage Disease Type V):**\n\n**DEFICIENCY:** **Muscle phosphorylase** (myophosphorylase) ‚≠ê‚≠ê‚≠ê\n\n**CLINICAL FEATURES (THIS CASE):**\n‚Ä¢ **Exercise-induced muscle cramps** ‚≠ê‚≠ê‚≠ê\n‚Ä¢ **Hypoglycemia** during exercise\n‚Ä¢ **\"Second wind\" phenomenon** ‚≠ê - symptoms improve after rest, then can continue exercising\n‚Ä¢ **Myoglobinuria** (dark urine after exercise)\n‚Ä¢ **NO hepatomegaly** (liver phosphorylase normal)\n\n**PATHOPHYSIOLOGY:**\n‚Ä¢ **Cannot break down muscle glycogen** ‚Üí No glucose for energy\n‚Ä¢ **Decreased lactate** during exercise ‚≠ê‚≠ê‚≠ê **(DIAGNOSTIC)**\n‚Ä¢ **Ischemic forearm test:** No rise in lactate after exercise\n\n**DIAGNOSIS:**\n‚Ä¢ **Decreased/absent serum lactate** during exercise ‚≠ê\n‚Ä¢ **Elevated CK** (muscle damage)\n‚Ä¢ **Muscle biopsy:** Glycogen accumulation, absent phosphorylase\n\n**TREATMENT:** Avoid strenuous exercise, oral glucose/fructose before activity\n\nüí° **KEY:** **Exercise cramps + Decreased lactate = McArdle disease** ‚≠ê‚≠ê‚≠ê",
    difficulty: "medium",
    year: 2023
  },{
    id: "neet-pg-2023-23",
    subjectId: "biochemistry",
    chapterId: "neet-pg-2023",
    question: "A family consumes only polished rice. Which of the following combinationsr of vitamin deficiency and enzymatic defect will be present in this family? e",
    options: [
      "Riboflavin-glutathione reductase",
      "Thiamine-transketolase",
      "Thiamine-transaminas d",
      "Riboflavin-transketolase",
    ],
    correctAnswer: 1,
    explanation: "‚úÖ ANSWER: **Thiamine-transketolase (Option B)**\n\nüî¨ **THIAMINE DEFICIENCY (Beriberi):**\n\n**POLISHED RICE:** Removes **thiamine-rich bran** ‚Üí Deficiency ‚≠ê‚≠ê‚≠ê\n\n**VITAMIN:** **Thiamine (Vitamin B1)**\n\n**ENZYMATIC DEFECT:** **Transketolase** ‚≠ê‚≠ê‚≠ê\n‚Ä¢ Key enzyme in **pentose phosphate pathway**\n‚Ä¢ Requires **TPP** (thiamine pyrophosphate) as cofactor\n\n**CLINICAL:** **Beriberi** (wet/dry) or **Wernicke-Korsakoff**\n\nüí° **KEY:** **Polished rice ‚Üí Thiamine deficiency ‚Üí Transketolase dysfunction** ‚≠ê‚≠ê‚≠ê",
    difficulty: "medium",
    imageUrl: "/images/questions/2023/page11_img7.jpeg",
    year: 2023
  },{
    id: "neet-pg-2023-24",
    subjectId: "biochemistry",
    chapterId: "neet-pg-2023",
    question: "p A chronic alcoholic patient presented to the casualty with confusion, ataxia, and painful eye movements. What could be the vitamin deficiency seen in this patient? e",
    options: [
      "Vitamin B deficiency",
      "Vitamin A deficiency OP3: Vitamin D deficiency O 4: Vitamin C deficiency",
      "Option 3",
      "Option 4",
    ],
    correctAnswer: 0,
    explanation: "‚úÖ ANSWER: **Vitamin B1 (Thiamine) deficiency (Option A)**\n\nüî¨ **WERNICKE'S ENCEPHALOPATHY:**\n\n**CLASSIC TRIAD** ‚≠ê‚≠ê‚≠ê:\n1. **Confusion** (encephalopathy)\n2. **Ataxia** (gait disturbance)\n3. **Ophthalmoplegia** (6th CN palsy - painful eye movements)\n\n**CAUSE:** **Thiamine (Vitamin B1) deficiency** ‚≠ê‚≠ê‚≠ê\n‚Ä¢ Common in **chronic alcoholics**\n\n**TREATMENT:** **IV Thiamine** (100mg) immediately ‚≠ê\n\nüí° **KEY:** **Alcoholic + Confusion + Ataxia + Eye movements = Wernicke's (Thiamine deficiency)** ‚≠ê‚≠ê‚≠ê",
    difficulty: "medium",
    year: 2023
  },{
    id: "neet-pg-2023-25",
    subjectId: "biochemistry",
    chapterId: "neet-pg-2023",
    question: "A 4-year-old child presents with easy fatigability. The mother also complains that the child has increased hunger between meals, which is relieved after food. Liver examination revealed no glycogen. The enzyme most likely deficient is?",
    options: [
      "Glycogen phosphorylase",
      "Glycogen synthase",
      "Debranching enzyme",
      "Glucose 6 phosphatas r",
    ],
    correctAnswer: 1,
    explanation: "‚úÖ ANSWER: **Glycogen synthase (Option B)**\n\nüî¨ **GSD TYPE 0 (Glycogen Synthase Deficiency):**\n\n**KEY FEATURE:** **NO glycogen in liver** ‚≠ê‚≠ê‚≠ê (cannot synthesize)\n\n**CLINICAL:**\n‚Ä¢ **Fasting hypoglycemia** ‚≠ê\n‚Ä¢ **Increased hunger between meals**\n‚Ä¢ **NO hepatomegaly** (no glycogen storage)\n\n**DEFICIENCY:** **Glycogen synthase** - cannot make glycogen ‚≠ê‚≠ê‚≠ê\n\nüí° **KEY:** **No hepatic glycogen + Fasting hypoglycemia = GSD Type 0 (Synthase deficiency)** ‚≠ê‚≠ê‚≠ê",
    difficulty: "medium",
    year: 2023
  },{
    id: "neet-pg-2023-26",
    subjectId: "biochemistry",
    chapterId: "neet-pg-2023",
    question: "A child was bought with pedal edema and cheilosdis. Cardiomegaly was present. What is the vitamin deficiency associated with this clinical presentation?",
    options: [
      "Riboflavin a",
      "Thiamin L",
      "Pyridoxine",
      "Niacin",
    ],
    correctAnswer: 1,
    explanation: "‚úÖ ANSWER: **Thiamine (Vitamin B1) (Option B)**\n\nüî¨ **WET BERIBERI:**\n\n**CLINICAL FEATURES (THIS CASE):**\n‚Ä¢ **Pedal edema** ‚≠ê (heart failure)\n‚Ä¢ **Cardiomegaly** ‚≠ê‚≠ê‚≠ê\n‚Ä¢ **Cheilosis** (cracked lips)\n\n**WET BERIBERI:** **High-output cardiac failure** from thiamine deficiency ‚≠ê‚≠ê‚≠ê\n\n**TREATMENT:** **Thiamine replacement**\n\nüí° **KEY:** **Edema + Cardiomegaly = Wet Beriberi (Thiamine deficiency)** ‚≠ê‚≠ê‚≠ê",
    difficulty: "medium",
    year: 2023
  },{
    id: "neet-pg-2023-27",
    subjectId: "biochemistry",
    chapterId: "neet-pg-2023",
    question: "P A chronic alcoholic patient is diagnosed with gouty arthritis. What biochemical changes will be s een in this patient?",
    options: [
      "Decreased NADH/NAD+ ratio",
      "Increased urea and urate levels",
      "Increased urate and lactate levels",
      "Increased level of alkaline phosphatase",
    ],
    correctAnswer: 2,
    explanation: "‚úÖ ANSWER: **Increased urate and lactate levels (Option C)**\n\nüî¨ **ALCOHOL + GOUT:**\n\n**ALCOHOL METABOLISM:**\n‚Ä¢ **Ethanol ‚Üí Acetaldehyde** (via alcohol dehydrogenase)\n‚Ä¢ **Increases NADH/NAD+ ratio** ‚≠ê‚≠ê‚≠ê\n\n**BIOCHEMICAL EFFECTS:**\n\n**1. Increased lactate** ‚≠ê:\n‚Ä¢ **High NADH** ‚Üí Pyruvate ‚Üí **Lactate** (LDH)\n‚Ä¢ **Lactic acidosis**\n\n**2. Increased urate** ‚≠ê‚≠ê‚≠ê:\n‚Ä¢ **Lactate competes** with urate for renal excretion\n‚Ä¢ ‚Üí **Decreased urate excretion**\n‚Ä¢ **Purine metabolism ‚Üë** (ATP degradation)\n‚Ä¢ ‚Üí **Hyperuricemia** ‚Üí **Gout**\n\nüí° **KEY:** **Alcohol ‚Üí ‚Üë NADH ‚Üí ‚Üë Lactate + ‚Üë Urate ‚Üí Gout** ‚≠ê‚≠ê‚≠ê",
    difficulty: "medium",
    year: 2023
  },{
    id: "neet-pg-2023-28",
    subjectId: "biochemistry",
    chapterId: "neet-pg-2023",
    question: "A child presents with erythematous scaly patches in the perioral region, mucosal ulcers, and impaired epithelial wound healing. The most likely mineral deficiency associated with this condition is?",
    options: [
      "Iron deficiency",
      "Zinc deficiency",
      "Calcium deficiency",
      "Copper deficiency d",
    ],
    correctAnswer: 1,
    explanation: "‚úÖ ANSWER: **Zinc deficiency (Option B)**\n\nüî¨ **ACRODERMATITIS ENTEROPATHICA (Zinc Deficiency):**\n\n**CLINICAL FEATURES (THIS CASE):**\n‚Ä¢ **Erythematous scaly patches** (perioral, periorificial) ‚≠ê‚≠ê‚≠ê\n‚Ä¢ **Mucosal ulcers**\n‚Ä¢ **Impaired wound healing** ‚≠ê\n‚Ä¢ **Diarrhea**\n‚Ä¢ **Alopecia**\n\n**ZINC DEFICIENCY:** ‚≠ê‚≠ê‚≠ê\n‚Ä¢ Essential for **wound healing**, **immunity**\n‚Ä¢ Cofactor for **>300 enzymes**\n\n**TREATMENT:** **Zinc supplementation**\n\nüí° **KEY:** **Perioral rash + Poor wound healing = Zinc deficiency** ‚≠ê‚≠ê‚≠ê",
    difficulty: "medium",
    year: 2023
  },{
    id: "neet-pg-2023-29",
    subjectId: "biochemistry",
    chapterId: "neet-pg-2023",
    question: "A patient presenting with bleeding gums and easy bruisability was diagnosed with scurvy. This is due to p",
    options: [
      "Low calcium e",
      "Defective collagen formation",
      "Inhibition of clotting factors OP4: Increased keratinization of epithelium A ns: 2",
      "Option 4",
    ],
    correctAnswer: 1,
    explanation: "‚úÖ ANSWER: **Defective collagen formation (Option B)**\n\nüî¨ **SCURVY (Vitamin C Deficiency):**\n\n**VITAMIN C (Ascorbic Acid):**\n‚Ä¢ Cofactor for **prolyl and lysyl hydroxylases** ‚≠ê‚≠ê‚≠ê\n‚Ä¢ **Hydroxylation** of proline/lysine ‚Üí **Stable collagen**\n\n**WITHOUT VITAMIN C:**\n‚Ä¢ **Defective collagen** formation ‚≠ê‚≠ê‚≠ê\n‚Ä¢ **Weak blood vessels** ‚Üí Bleeding\n\n**CLINICAL (THIS CASE):**\n‚Ä¢ **Bleeding gums** ‚≠ê\n‚Ä¢ **Easy bruising** (perifollicular hemorrhage)\n‚Ä¢ **Poor wound healing**\n‚Ä¢ **Bone pain** (subperiosteal hemorrhage)\n\n**TREATMENT:** **Vitamin C supplementation**\n\nüí° **KEY:** **Scurvy = Defective collagen ‚Üí Bleeding** ‚≠ê‚≠ê‚≠ê",
    difficulty: "medium",
    year: 2023
  },{
    id: "neet-pg-2023-30",
    subjectId: "biochemistry",
    chapterId: "neet-pg-2023",
    question: "Which of the following is seen in low insulin: glucagon ratio?",
    options: [
      "Activation of lipoprotein lipase",
      "Activation of glycogen synthase",
      "Activation of phosphofructokinase 1",
      "Activation of hormone-sensitive lipase",
    ],
    correctAnswer: 3,
    explanation: "‚úÖ ANSWER: **Activation of hormone-sensitive lipase (Option D)**\n\nüî¨ **LOW INSULIN:GLUCAGON RATIO (Fasting State):**\n\n**GLUCAGON DOMINANT** ‚≠ê‚≠ê‚≠ê:\n\n**EFFECTS:**\n‚Ä¢ **Activates hormone-sensitive lipase** ‚≠ê‚≠ê‚≠ê ‚Üí **Lipolysis** (fat breakdown)\n‚Ä¢ **Activates** gluconeogenesis, glycogenolysis\n‚Ä¢ **Inhibits** glycogen synthase, lipogenesis\n\n**RESULT:** **Catabolic state** - breakdown of stores\n\nüí° **KEY:** **Low insulin:glucagon ‚Üí Glucagon dominant ‚Üí HSL activation ‚Üí Lipolysis** ‚≠ê‚≠ê‚≠ê",
    difficulty: "medium",
    year: 2023
  },{
    id: "neet-pg-2023-31",
    subjectId: "biochemistry",
    chapterId: "neet-pg-2023",
    question: "e An infant is brought by his parents with complaints that his urine turns black on standing. Which of the following metabolic disorders is likely? d",
    options: [
      "Phenylketonuria",
      "Alkaptonuria",
      "Homocystinuria a",
      "Maple syrup urine diseas L",
    ],
    correctAnswer: 1,
    explanation: "‚úÖ ANSWER: **Alkaptonuria (Option B)**\n\nüî¨ **ALKAPTONURIA:**\n\n**DEFICIENCY:** **Homogentisate oxidase** ‚≠ê‚≠ê‚≠ê\n\n**CLASSIC SIGN:** **Urine turns black on standing** ‚≠ê‚≠ê‚≠ê (homogentisic acid oxidation)\n\n**CLINICAL:**\n‚Ä¢ **Dark urine** (infant/child)\n‚Ä¢ **Ochronosis** (dark pigmentation - cartilage, sclera) - adult\n‚Ä¢ **Arthritis** (spine, large joints) - adult\n\n**INHERITANCE:** Autosomal recessive\n\nüí° **KEY:** **Black urine = Alkaptonuria** ‚≠ê‚≠ê‚≠ê",
    difficulty: "medium",
    year: 2023
  },{
    id: "neet-pg-2023-32",
    subjectId: "biochemistry",
    chapterId: "neet-pg-2023",
    question: "Question 32 - [Content needs manual review]",
    options: [
      "Option 1",
      "Option 2",
      "Biotin",
      "Thiamine",
    ],
    correctAnswer: 2,
    explanation: "‚úÖ ANSWER: **Biotin**\n\nüî¨ Detailed explanation to be added.",
    difficulty: "medium",
    year: 2023
  },{
    id: "neet-pg-2023-33",
    subjectId: "biochemistry",
    chapterId: "neet-pg-2023",
    question: "A child presents with mental retardation, bone pain, and inability to walk. On funduscopic examination, a cherry red spot is seen. There is no organomegaly. What is the most likely diagnosis?",
    options: [
      "Tay-Sachs disease",
      "Niemann-Pick disease r",
      "Hurler syndrome",
      "Gaucher diseas d",
    ],
    correctAnswer: 0,
    explanation: "‚úÖ ANSWER: **Tay-Sachs disease (Option A)**\n\nüî¨ **TAY-SACHS DISEASE:**\n\n**DEFICIENCY:** **Hexosaminidase A** ‚≠ê‚≠ê‚≠ê\n‚Ä¢ **GM2 ganglioside accumulation**\n\n**KEY FEATURES (THIS CASE):**\n‚Ä¢ **Cherry-red spot** on macula ‚≠ê‚≠ê‚≠ê\n‚Ä¢ **NO organomegaly** ‚≠ê (only CNS affected)\n‚Ä¢ **Mental retardation**\n‚Ä¢ **Hypotonia** ‚Üí **Spasticity**\n‚Ä¢ **Seizures**\n‚Ä¢ **Blindness**\n\n**VS OTHER LIPIDOSES:**\n‚Ä¢ **Niemann-Pick:** Cherry-red spot **+ hepatosplenomegaly**\n‚Ä¢ **Gaucher:** **Hepatosplenomegaly**, NO cherry-red spot\n\n**INHERITANCE:** Autosomal recessive (Ashkenazi Jews)\n\nüí° **KEY:** **Cherry-red spot + NO organomegaly = Tay-Sachs** ‚≠ê‚≠ê‚≠ê",
    difficulty: "medium",
    year: 2023
  },{
    id: "neet-pg-2023-170",
    subjectId: "biochemistry",
    chapterId: "neet-pg-2023",
    question: "d A child presents with bone pain and hepatosplenomegaly. A trephine biopsy and aspirate show the following finding. Which of the following is the most likely enzyme deficient in this condition? a L p e r P",
    options: [
      "H exosaminidase",
      "Glucocerebrosidase",
      "Sphingomyelinase",
      "Alpha 1,4-glucosidase",
    ],
    correctAnswer: 1,
    explanation: "‚úÖ ANSWER: **Glucocerebrosidase (Option B)**\n\nüî¨ **GAUCHER DISEASE:**\n\n**ENZYME DEFICIENCY:** **Glucocerebrosidase** (Œ≤-glucosidase) ‚≠ê‚≠ê‚≠ê\n\n**THIS CASE:**\n‚Ä¢ **Bone pain** ‚≠ê\n‚Ä¢ **Hepatosplenomegaly** ‚≠ê‚≠ê‚≠ê\n‚Ä¢ **Biopsy:** (From image) Gaucher cells ‚≠ê‚≠ê‚≠ê\n\n**GAUCHER CELLS:** ‚≠ê‚≠ê‚≠ê **(PATHOGNOMONIC)**\n‚Ä¢ **Macrophages** filled with glucocerebroside\n‚Ä¢ **Crumpled tissue paper** appearance ‚≠ê‚≠ê‚≠ê\n‚Ä¢ **Wrinkled cytoplasm**\n\n**CLINICAL - TYPE 1** (Most common, non-neuropathic):\n‚Ä¢ **Hepatosplenomegaly** ‚≠ê‚≠ê‚≠ê (massive spleen)\n‚Ä¢ **Bone pain** ‚≠ê (Erlenmeyer flask deformity)\n‚Ä¢ **Thrombocytopenia** (hypersplenism)\n‚Ä¢ **NO CNS involvement**\n\n**OTHER TYPES:**\n‚Ä¢ **Type 2:** Acute neuronopathic (infantile)\n‚Ä¢ **Type 3:** Chronic neuronopathic\n\n**TREATMENT:**\n‚Ä¢ **Enzyme replacement** ‚≠ê‚≠ê‚≠ê (Imiglucerase)\n‚Ä¢ **Splenectomy** (if massive)\n\n**OTHER LYSOSOMAL STORAGE:**\n‚Ä¢ **Hexosaminidase:** Tay-Sachs\n‚Ä¢ **Sphingomyelinase:** Niemann-Pick\n\nüí° **KEY:** **Gaucher cells (wrinkled) = Glucocerebrosidase deficiency** ‚≠ê‚≠ê‚≠ê",
    difficulty: "medium",
    imageUrl: "/images/questions/2023/page84_img43.jpeg",
    year: 2023
  }
];

export default questions;

// Helper function to get questions by chapter
export function getQuestionsByChapter(chapterId: string): Question[] {
  return questions.filter(q => q.chapterId === chapterId);
}

// Export question count
export const questionCount = questions.length;
